23 Mar 2021 Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases Member news
22 Mar 2021 Biocartis launches Idylla™ GeneFusion Assay as rapid lab workflow solution for gene fusion testing Member news
22 Mar 2021 ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version Member news
22 Mar 2021 Consortium led by eTheRNA immunotherapies awarded EU Commission TIGER Grant of EUR 6.9 million Member news
19 Mar 2021 Augustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board Member news
18 Mar 2021 FOx BIOSYSTEMS launches the White FOx, its new generation biosensor with fiber-optic surface plasmon resonance Member news
18 Mar 2021 Augustine Therapeutics appoints Sylvain Celanire as CEO to accelerate development of innovative medicines for rare neuromuscular diseases Member news
11 Mar 2021 Complix signs global drug discovery and development agreement with I-Mab to develop cell penetrating alphabodies against two intracellular immuno-oncology targets Member news
11 Mar 2021 eTheRNA extends leadership team with the appointment of Dr. Volker Germaschewski as Senior Vice President for R&D Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
